Company Overview : Sahajanand medical technologies

A leading developer and manufacturer of minimally invasive coronary stent systems, with one of the
broadest product portfolio in the industry. They have a strong international presence with global
footprints in more than 65 countries

The company offers eluting cobalt chromium coronary stent systems; balloon expandable cobalt
chromium renal and biliary stent systems; dilatation catheters; Y-adaptor, inflation device, aspiration
catheter, and radial artery compression device; and guiding platelet therapy and IT systems for research.
It serves healthcare professionals. The company was founded in 1997 and is based in Surat, India.
Sahajanand Medical Technologies Pvt. Ltd. operates as a subsidiary Sahajanand Technologies (P) Ltd.

Founded by Mr. Dhirajlal Kotadia in 2001, SMT became an early champion of the ‘Make in India’
initiative by being one of the first companies in Asia to indigenously develop & manufacture coronary
stents. Today, SMT is the largest developer, manufacturer and market leader of minimally invasive
coronary stents (drug-eluting & bare metal), renal stents, PTCA balloon catheters and other cardio
vascular accessories in India. Beyond India, SMT also exports its portfolio of life saving devices to UK,
Spain, Italy, Netherlands & over 60 other countries.

SMT operates a WHO-GMP certified manufacturing plant in Gujarat and two world-class R&D centers,
including one in Ireland. The Company has a strong focus on R&D and has a number of pioneering
achievements to its credit including being the first company in the world to receive the CE certification
for a drug eluting stent with biodegradable polymer. Further, SMT has published several clinical studies
in leading cardiac journals and has multiple process/product patents. The company keeps a highly
customer-centric approach while distributing its innovative products & technologies through a well-
entrenched direct sales network.

URL - https://smtpl.com